Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abbv crawled time : 15:20 save search
AbbVie Advances Upadacitinib (RINVOQ®) to Phase 3 Clinical Trials in Systemic Lupus Erythematosus
Published: 2023-03-23 (Crawled : 15:20) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.28%
H: 1.56%
C: 0.78%
rinvoq abbvie lupus trials
The Global Diffuse Large B-Cell Lymphoma (DLBCL) Therapeutics Market is forecast to grow by $ 2061.88 mn during 2022-2027, accelerating at a CAGR of 7.96% during the forecast period
Published: 2023-03-15 (Crawled : 15:20) - prnewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 2.62%
H: 0.0%
C: -3.57%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -1.0%
H: 1.39%
C: 1.02%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -0.95%
H: 1.05%
C: 0.54%
ADCT | $4.72 -0.84% 0.0% 320K
|
Health Technology
|
| O: -0.81%
H: 3.48%
C: -0.82%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.09%
H: 1.45%
C: 1.24%
CTIC | $9.09 0.05% 11M
|
Health Technology
|
| O: 0.67%
H: 0.67%
C: -2.22%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.08%
H: 2.24%
C: 1.95%
global therapeutics market
Providence Therapeutics Appoints Robert Georgantas, Ph.D. as President and Chief Technology Officer
Published: 2023-02-01 (Crawled : 15:20) - biospace.com/
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.76%
H: 0.55%
C: -0.02%
technology therapeutics
Global Bio-Pharma Market is Expected to reach USD 703.28 Billion by 2027 at 12.5% CAGR, Says Brandessence Market Research
Published: 2022-09-13 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -4.5%
H: 0.0%
C: 0.0%
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.78%
H: 0.0%
C: 0.0%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: -1.39%
H: 0.31%
C: -1.16%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.19%
H: 0.98%
C: -1.44%
XERS | $1.73 -1.7% -1.73% 2M
|
Health Technology
|
| O: -4.92%
H: 5.17%
C: 2.87%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.97%
H: 0.16%
C: -0.98%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: -2.2%
H: 0.2%
C: -2.32%
AMGN | $269.03 2.39% 2.33% 3.4M
|
Health Technology
|
| O: -0.25%
H: 0.05%
C: -4.29%
research global expected market
Genmab Announces Financial Results for the First Half of 2022
Published: 2022-08-10 (Crawled : 15:20) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.39%
H: 5.07%
C: -0.05%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 1.0%
H: 0.01%
C: -0.67%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.47%
H: 0.11%
C: 0.02%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: 2.33%
H: 0.64%
C: -0.72%
Facial Aesthetics Market: USD 1.45 billion Growth from 2020 to 2025 | High Competition in the Market due to the Presence of Region-specific Vendors| Technavio
Published: 2022-06-14 (Crawled : 15:20) - prnewswire.com
BHC | $8.69 1.05% 0.0% 2.9M
|
Health Technology
|
| O: -0.26%
H: 0.73%
C: -2.12%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -1.04%
H: 0.87%
C: -1.31%
ANIK | $25.84 1.61% 1.59% 49K
|
Health Technology
|
| O: 0.2%
H: 0.54%
C: -0.1%
growth market
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in AbbVie Inc. with Losses of $100,000 to Contact the Firm
Published: 2022-06-06 (Crawled : 15:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.12%
H: 0.56%
C: -0.32%
deadline
Antiviral Drugs Market is expected to grow at a steady pace by 2027 | CAGR: 3.4% | UnivDatos Market Insights
Published: 2022-05-30 (Crawled : 15:20) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
| Email alert
Add to watchlist
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
| Email alert
Add to watchlist
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
| Email alert
Add to watchlist
antiviral expected market drug
AbbVie, Inc. Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds ABBV Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
Published: 2022-05-26 (Crawled : 15:20) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.12%
H: 0.0%
C: 0.0%
Genmab Announces Financial Results for the First Quarter of 2022
Published: 2022-05-11 (Crawled : 15:20) - globenewswire.com
GNMSF | $290.38 3.83% 220
|
Health Technology
|
| O: -0.51%
H: 2.39%
C: -0.57%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.81%
H: 0.0%
C: -0.09%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: 0.27%
H: 1.2%
C: -0.85%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.87%
H: 0.0%
C: 0.0%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
HALO M | $38.64 2.2% 2.15% 1.3M
|
Health Technology
|
| O: 0.94%
H: 2.18%
C: 0.05%
GMAB | $28.72 1.38% 1.36% 360K
|
Health Technology
|
| O: -0.54%
H: 0.96%
C: -4.44%
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
NYC 4 | $5.91 -4.83% 14.38% 770
|
Finance
MGOL 4 | $0.229 -4.18% 13.72% 420K
|
GBR | $1.42 31.48% 11.27% 990K
|
Energy Minerals
DEO | News | $140.76 -0.02% 8.27% 560K
|
Consumer Non-Durables
KUKE | $2.88 2.49% 7.64% 360K
|
MGLD 4 | $1.23 8.85% 7.32% 14K
|
Manufacturing
GRFX | $0.2116 -1.58% 7.28% 40K
|
n/a
LYT | $4.22 4.72% 5.62% 1.4M
|
SYY | $76.73 1.44% 5.49% 2.5M
|
Distribution Services
Your saved searches
Save your searches and get alerts when important news are released.